NEUTROGUARD study: Phase III clinical study of DEFENCATH for prevention of CLABSI in adults on TPN via central venous catheter.

Strategic focus now centers on further automation and employer-related growth, as expense reductions are planned to be reinvested according to the company's multi-year performance model. Management ...

As Republicans openly fret about Texas after Democrat James Talarico’s primary victory, a Dem operative who knows the state ...

Net sales rose 266% to $41.3 million; gross sales increased 337%. Stoker's Segment -- Net sales of $81 million, up 70%, including a 9% gain in legacy brands (to $39.7 million) and the 266% Modern Oral ...

Morgan Stanley Technology, Media & Telecom Conference 2026 March 4, 2026 6:20 PM ESTCompany ParticipantsDaniel Danker - ...

Discusses Sale of Connectivity Business to Accenture and Strategic Implications March 3, 2026 4:30 PM ESTCompany ...

Turning Point Brands, Inc. (NYSE:TPB) Q4 2025 Earnings Call Transcript March 2, 2026 Turning Point Brands, Inc. beats ...

Indiana men's basketball junior guard Nick Dorn and senior forward Tucker DeVries met with the media after beating Minnesota at Simon Skjodt Assembly Hall.

Gross Margin -- 20.4% for the year, falling from 37.4%, primarily because of nonrecurring high-margin license deliveries and ...

Manchester United head coach Michael Carrick has said Luke Shaw is "in a good place" in terms of his availability and ...

Upland Software, Inc. (NASDAQ:UPLD) Q4 2025 Earnings Call Transcript March 3, 2026 Upland Software, Inc. misses on earnings ...

The full transcript from Chelsea head coach Liam Rosenior's pre-match press conference ahead of the Blues' trip to take on ...